Irisin improves glucose homeostasis after long-term moderate physical exercises, suggesting that irisin could have regulatory effect on glucose, insulin resistance, and obesity and it could be used as a potential therapy for obesity and insulin resistance. The gene discussed is FNDC5; the disease is obesity due to melanocortin 4 receptor deficiency.